Mylène Vaillancourt
-
- Pulmonary Hypertension Research and Treatments 8
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- MicroRNA in disease regulation 2
-
- Antibiotic Resistance in Bacteria 3
-
- Bacterial biofilms and quorum sensing 4
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 2
-
- Vibrio bacteria research studies 2
-
- Vascular Anomalies and Treatments 2
- Co-authors
- Grégoire RuffenachSébastien BonnetJolyane MelocheSteeve ProvencherMansoureh EghbaliÈve TremblayFrançois PotusSandra Breuils‐Bonnet
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Mylène Vaillancourt
17 papers receiving 739 citations
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 495
- Cardiology and Cardiovascular Medicine 230
- Cancer Research 126
- Molecular Medicine 30
- Molecular Biology 254
Countries citing papers authored by Mylène Vaillancourt
This map shows the geographic impact of Mylène Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène Vaillancourt more than expected).
Fields of papers citing papers by Mylène Vaillancourt
This network shows the impact of papers produced by Mylène Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène Vaillancourt. The network helps show where Mylène Vaillancourt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mylène Vaillancourt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 20 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 56 | |
| 8 | 2020 | 14 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 15 | |
| 12 | 2017 | 97 | |
| 13 | 2015 | 133 | |
| 14 | 2014 | 86 | |
| 15 | 2014 | 23 | |
| 16 | 2013 | 198 | |
| 17 | 2013 | 24 | |
| 18 | 2010 | 24 |
About Mylène Vaillancourt
Mylène Vaillancourt is a scholar working on Molecular Medicine, Endocrinology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 749 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (8 papers), Bacterial biofilms and quorum sensing (4 papers), Antibiotic Resistance in Bacteria (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Vibrio bacteria research studies (2 papers), MicroRNA in disease regulation (2 papers) and Vascular Anomalies and Treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (495 citations), Cardiology and Cardiovascular Medicine (230 citations) and Cancer Research (126 citations). Mylène Vaillancourt has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Grégoire Ruffenach, Sébastien Bonnet, Jolyane Meloche, Steeve Provencher, Mansoureh Eghbali, Ève Tremblay, François Potus, Sandra Breuils‐Bonnet, Colin Graydon and Aude Pflieger. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.